Key Highlights
- Maggie Chen, with over 20 years of experience, appointed as Senior Vice President and Site Head at KBI Biopharma’s Patriot Park facility.
- Chen’s background includes roles at Johnson & Johnson, Spectranetics, Novartis, and AGC Biologics, highlighting her expertise in manufacturing and engineering.
- The Patriot Park site focuses on mammalian-based product manufacturing and is embracing Manufacturing 4.0 principles and sustainability practices.
Source: Business Wire
Notable Quotes
- “I am incredibly grateful for the opportunity to join the KBI team at Patriot Park. KBI has built a strong reputation with a high customer satisfaction rating, and this location is primed to continue to deliver at an exceptional level for our commercial customers.” – Maggie Chen, Senior Vice President at KBI Biopharma
- “I am confident that [Maggie’s] passion for cross-functional collaboration and expertise in operational readiness and program management will be valued at the facility, across the KBI network, and in customer interactions.” – Tony Fraij, COO at KBI Biopharma
SoH's Take
Maggie Chen’s appointment as Senior Vice President and Site Head at KBI Biopharma’s Patriot Park is a strategic move that speaks volumes about the company’s commitment to excellence and innovation. Chen’s vast experience in various leading roles within the biopharmaceutical industry positions her as an ideal leader to drive the facility’s mission forward. Her expertise in manufacturing and engineering, combined with a focus on Manufacturing 4.0 principles, sets the stage for Patriot Park to enhance its capabilities in producing high-quality drug substances. This development not only underscores KBI’s dedication to maintaining high standards in biopharmaceutical manufacturing but also highlights its role in advancing the broader life sciences sector through technological and sustainable practices.
